Navigating the holidays while facing a cancer diagnosis can feel overwhelming. We asked three cancer survivors for their advice on how to manage this season. Find out what they recommend via Katie Couric Media: https://bit.ly/3ZK1ZMO
Exact Sciences
Badania w zakresie biotechnologii
Madison, Wisconsin 120 170 obserwujących
Informacje
At Exact Sciences, our purpose is to help eradicate cancer by preventing it, detecting it earlier, and guiding personalized treatment. We're hiring! Our organization offers something for everyone, at all stages of careers and from all backgrounds. Let's take on cancer, together.
- Witryna
-
http://exactsciences.com
Link zewnętrzny organizacji Exact Sciences
- Branża
- Badania w zakresie biotechnologii
- Wielkość firmy
- 5 001-10 000 pracowników
- Siedziba główna
- Madison, Wisconsin
- Rodzaj
- Spółka akcyjna
- Specjalizacje
- Precision oncology, Genomic testing, Cancer screening, Genetic testing i Research and development
Lokalizacje
Pracownicy Exact Sciences
Aktualizacje
-
Kevin Conroy recently sat down with Chase Feiger, M.D. to discuss the importance of early cancer detection and what the future of screening may look like. Listen here: https://spoti.fi/4gmg0Y4. Kinara
-
As we head into the holidays, teams across Exact Sciences are celebrating a tremendous 2024. We’re grateful for our amazing teammates who are committed to patient-focused work all year long. Wishing everyone a joyful and safe holiday season, and a fantastic 2025! #WeAreExact
-
+3
-
We’re feeling inspired after hosting our patient advocacy partners for a fireside chat where we reflected on the impact of cancer diagnostic testing in the last 20 years. We’ve come a long way in personalized cancer care, and the next 20 years look even more promising! #SABCS24 Special thanks to our panelists: Debbie Denardi - MBA, Punita Khanna, Betty M SANCHEZ
-
Our very own Tomasz (Tom) Beer recently sat down on the #HealthcareUnfiltered podcast to discuss the science behind multi-cancer early detection (MCED) testing and how these tests may be able to improve patient outcomes. Listen to the full podcast: https://lnkd.in/gqQMpz3w Chadi Nabhan, MD, MBA,FACP
-
Rick Baehner, MD checking in from San Antonio, Texas as the team attends #SABCS24! We’re looking forward to connecting with industry peers and advocacy partners to highlight the impact of the Oncotype DX® and OncoExTra® tests in cancer care. https://lnkd.in/g-r-D99W
-
Matching job seekers with work goes beyond a resume at PreventionGenetics. Discover how the team is collaborating with Opportunity Development Centers, Inc. to help create work opportunities for people with disabilities: https://bit.ly/3ZFb9v7
Matching workers with work
exactsciences.com
-
We were thrilled to welcome Office of Management and Budget Director Shalanda Young and US Representative Mark Pocan to our Cologuard and Multi-Cancer Early Detection (MCED) laboratory facilities in Madison this week. It was an honor to showcase how Exact Sciences is innovating the future of cancer testing.
-
The most important #2 ever dropped. Learn more: https://bit.ly/3Zf87wg #getlow2 #preventcoloncancer
Powiązane strony
Podobne strony
Akcje
EXAS
NASDAQ
20 minut opóźnienia
58,11 USD
-0,82 (-1,392%)
- Otwarcie giełdy
- 58,21
- Min.
- 57,64
- Maks.
- 58,95
Dane z Refinitiv
Zobacz więcej informacji oFinansowanie
Ostatnia runda
Zadłużenie po IPO620 700 000,00 USD